[
    {
        "title": "Is it Time to Dump Celldex Therapeutics, Inc. (CLDX) Stock After it Has Risen 7.55% in a Week? - InvestorsObserver",
        "description": "Is it Time to Dump Celldex Therapeutics, Inc. (CLDX) Stock After it Has Risen 7.55% in a Week?  InvestorsObserver",
        "published date": "Thu, 28 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5pbnZlc3RvcnNvYnNlcnZlci5jb20vbmV3cy9zdG9jay11cGRhdGUvaXMtaXQtdGltZS10by1kdW1wLWNlbGxkZXgtdGhlcmFwZXV0aWNzLWluYy1jbGR4LXN0b2NrLWFmdGVyLWl0LWhhcy1yaXNlbi03LTU1LWluLWEtd2Vla9IBkAFodHRwczovL3d3dy5pbnZlc3RvcnNvYnNlcnZlci5jb20vbmV3cy9zdG9jay11cGRhdGUvYW1wL2lzLWl0LXRpbWUtdG8tZHVtcC1jZWxsZGV4LXRoZXJhcGV1dGljcy1pbmMtY2xkeC1zdG9jay1hZnRlci1pdC1oYXMtcmlzZW4tNy01NS1pbi1hLXdlZWs?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.investorsobserver.com",
            "title": "InvestorsObserver"
        }
    },
    {
        "title": "Cantor Fitzgerald Reiterates Celldex Therapeutics (CLDX ... - Nasdaq",
        "description": "Cantor Fitzgerald Reiterates Celldex Therapeutics (CLDX ...  Nasdaq",
        "published date": "Fri, 13 Oct 2023 08:20:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvY2FudG9yLWZpdHpnZXJhbGQtcmVpdGVyYXRlcy1jZWxsZGV4LXRoZXJhcGV1dGljcy1jbGR4LW92ZXJ3ZWlnaHQtcmVjb21tZW5kYXRpb24tMdIBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.nasdaq.com",
            "title": "Nasdaq"
        }
    },
    {
        "title": "Despite shrinking by US$70m in the past week, Celldex Therapeutics (NASDAQ:CLDX) shareholders are still up 346% over 5 years - Simply Wall St",
        "description": "Despite shrinking by US$70m in the past week, Celldex Therapeutics (NASDAQ:CLDX) shareholders are still up 346% over 5 years  Simply Wall St",
        "published date": "Thu, 05 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimgFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1jbGR4L2NlbGxkZXgtdGhlcmFwZXV0aWNzL25ld3MvZGVzcGl0ZS1zaHJpbmtpbmctYnktdXM3MG0taW4tdGhlLXBhc3Qtd2Vlay1jZWxsZGV4LXRoZXJhcGV10gGeAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbmFzZGFxLWNsZHgvY2VsbGRleC10aGVyYXBldXRpY3MvbmV3cy9kZXNwaXRlLXNocmlua2luZy1ieS11czcwbS1pbi10aGUtcGFzdC13ZWVrLWNlbGxkZXgtdGhlcmFwZXUvYW1w?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://simplywall.st",
            "title": "Simply Wall St"
        }
    },
    {
        "title": "Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance",
        "description": "Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates  Yahoo Finance",
        "published date": "Tue, 08 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9jZWxsZGV4LXRoZXJhcGV1dGljcy1jbGR4LXJlcG9ydHMtcTItMjEzMDE1ODE2Lmh0bWzSAVpodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9jZWxsZGV4LXRoZXJhcGV1dGljcy1jbGR4LXJlcG9ydHMtcTItMjEzMDE1ODE2Lmh0bWw?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "We Think Celldex Therapeutics (NASDAQ:CLDX) Can Afford To Drive Business Growth - Simply Wall St",
        "description": "We Think Celldex Therapeutics (NASDAQ:CLDX) Can Afford To Drive Business Growth  Simply Wall St",
        "published date": "Fri, 07 Jul 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimgFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1jbGR4L2NlbGxkZXgtdGhlcmFwZXV0aWNzL25ld3Mvd2UtdGhpbmstY2VsbGRleC10aGVyYXBldXRpY3MtbmFzZGFxY2xkeC1jYW4tYWZmb3JkLXRvLWRyaXZl0gGeAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbmFzZGFxLWNsZHgvY2VsbGRleC10aGVyYXBldXRpY3MvbmV3cy93ZS10aGluay1jZWxsZGV4LXRoZXJhcGV1dGljcy1uYXNkYXFjbGR4LWNhbi1hZmZvcmQtdG8tZHJpdmUvYW1w?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://simplywall.st",
            "title": "Simply Wall St"
        }
    },
    {
        "title": "Celldex Therapeutics Enters Oversold Territory (CLDX) - Nasdaq",
        "description": "Celldex Therapeutics Enters Oversold Territory (CLDX)  Nasdaq",
        "published date": "Wed, 09 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvY2VsbGRleC10aGVyYXBldXRpY3MtZW50ZXJzLW92ZXJzb2xkLXRlcnJpdG9yeS1jbGR4LTDSAQA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.nasdaq.com",
            "title": "Nasdaq"
        }
    },
    {
        "title": "Why Celldex Therapeutics Shares Are Trading Higher Today - Yahoo Finance",
        "description": "Why Celldex Therapeutics Shares Are Trading Higher Today  Yahoo Finance",
        "published date": "Mon, 27 Feb 2023 08:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktY2VsbGRleC10aGVyYXBldXRpY3Mtc2hhcmVzLXRyYWRpbmctMTUyNTUyMzI0Lmh0bWzSAV1odHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy93aHktY2VsbGRleC10aGVyYXBldXRpY3Mtc2hhcmVzLXRyYWRpbmctMTUyNTUyMzI0Lmh0bWw?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "Celldex Skids As It Takes On A Blockbuster Roche, Novartis Drug - Investor's Business Daily",
        "description": "Celldex Skids As It Takes On A Blockbuster Roche, Novartis Drug  Investor's Business Daily",
        "published date": "Fri, 01 Jul 2022 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2NsZHgtc3RvY2stc2tpZHMtYXMtaXQtdGFrZXMtb24tbm92YXJ0aXMtcm9jaGUtYmxvY2tidXN0ZXItZHJ1Zy_SAQA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.investors.com",
            "title": "Investor's Business Daily"
        }
    },
    {
        "title": "Celldex Therapeutics Stock Forecast, Price & News (NASDAQ:CLDX) - MarketBeat",
        "description": "Celldex Therapeutics Stock Forecast, Price & News (NASDAQ:CLDX)  MarketBeat",
        "published date": "Fri, 05 Jun 2015 09:00:18 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiLmh0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL3N0b2Nrcy9OQVNEQVEvQ0xEWC_SAQA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.marketbeat.com",
            "title": "MarketBeat"
        }
    },
    {
        "title": "Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News ... - Benzinga",
        "description": "Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News ...  Benzinga",
        "published date": "Sun, 27 Dec 2020 10:29:05 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiI2h0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9xdW90ZS9DTERY0gEA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.benzinga.com",
            "title": "Benzinga"
        }
    }
]